Epidemiology Of Chronic Disease

by Randall E. Harris (Author)
Epidemiology of Chronic Disease: Global Perspectives is the most current and authoritative resource on the epidemiology, etiology, pathogenesis, risk factors and preventive factors of over 50 major chronic diseases and conditions. This comprehensive text provides readers with an excellent basis for examining current hypotheses regarding chronic disease epidemiology

This book tackles the difficult challenge of uncovering the pathogenic cause, epidemiological mechanics and broader historical impacts of an extremely deadly third-century ancient Roman pandemic. The core of this research is embodied in a novel systems synthesis methodology that allows for ground-breaking historical-scientific problem-solving. Through precise historical and scientific problem-solving, analysis and modelling, the authors piece together a holistic puzzle portrait of an ancient plague that is fully consistent, in turn, with both the surviving ancient evidence and the latest in cutting edge twenty-first-century modern medical and molecular phylogenetic science. Demonstrating the broader relevance of the crisis-beset world of the third-century Roman Empire in providing guiding and cautionary historical lessons for the present, this innovative book provides fascinating insights for students and scholars across a range of disciplines.

This book provides a comprehensive overview of celiac disease, presenting information on its diagnosis and management.

This book has been designed to deliver the detailed knowledge about the various respiratory infections including viral, bacterial, and helminthic infections.

This book provides clinicians with the information needed to effectively interpret the literature from observational and interventional cardiovascular outcomes studies. The book begins by providing a historical context of cardiovascular epidemiology, followed by chapters addressing key concepts in the study of cardiovascular disease such as the types of cardiovascular outcomes studies, basic and evolving design and statistical considerations, current guidelines for reducing atherosclerotic cardiovascular disease risk, surrogate markers of cardiovascular disease, challenges in developing evidence-based recommendations for non-pharmacological interventions, an overview of the pharmaceutical development process, and a detailed discussion of the clinical evidence supporting several factors and their relationships with atherosclerotic cardiovascular disease (lipids, inflammation, hemostasis, heart rhythm, blood pressure, diabetes, obesity, and chronic kidney disease).